| Dietary phytochemicals and cancer chemoprevention: a review of the clinical evidence R Kotecha, A Takami, JL Espinoza Oncotarget 7 (32), 52517, 2016 | 412 | 2016 |
| Tumor microenvironment dynamics in clear-cell renal cell carcinoma L Vuong, RR Kotecha, MH Voss, AA Hakimi Cancer discovery 9 (10), 1349-1357, 2019 | 321 | 2019 |
| Towards individualized therapy for metastatic renal cell carcinoma RR Kotecha, RJ Motzer, MH Voss Nature reviews Clinical oncology 16 (10), 621-633, 2019 | 193 | 2019 |
| Checkpoint inhibition of KIR2D with the monoclonal antibody IPH2101 induces contraction and hyporesponsiveness of NK cells in patients with myeloma M Carlsten, N Korde, R Kotecha, R Reger, S Bor, D Kazandjian, ... Clinical Cancer Research 22 (21), 5211-5222, 2016 | 186 | 2016 |
| Phase II trial of cabozantinib plus nivolumab in patients with non–clear-cell renal cell carcinoma and genomic correlates CH Lee, MH Voss, MI Carlo, YB Chen, M Zucker, A Knezevic, ... Journal of Clinical Oncology 40 (21), 2333-2341, 2022 | 141 | 2022 |
| Outcomes of patients with metastatic clear-cell renal cell carcinoma treated with second-line VEGFR-TKI after first-line immune checkpoint inhibitors AY Shah, RR Kotecha, EA Lemke, A Chandramohan, JL Chaim, ... European Journal of Cancer 114, 67-75, 2019 | 114 | 2019 |
| Interventions to Improve Oral Chemotherapy Safety and Quality: A Systematic Review JA Zerillo, BA Goldenberg, RR Kotecha, AK Tewari, JO Jacobson, ... JAMA oncology, 2017 | 103 | 2017 |
| Comprehensive molecular characterization and response to therapy in fumarate hydratase–deficient renal cell carcinoma JP Gleeson, I Nikolovski, R Dinatale, M Zucker, A Knezevic, S Patil, Y Ged, ... Clinical Cancer Research 27 (10), 2910-2919, 2021 | 67 | 2021 |
| Are wet-induced wrinkled fingers primate rain treads? M Changizi, R Weber, R Kotecha, J Palazzo Brain Behavior and Evolution 77 (4), 286-290, 2011 | 59 | 2011 |
| PD-1 directed immunotherapy alters Tfh and humoral immune responses to seasonal influenza vaccine RS Herati, DA Knorr, LA Vella, LV Silva, L Chilukuri, SA Apostolidis, ... Nature immunology 23 (8), 1183-1192, 2022 | 58 | 2022 |
| Phase II study of neoadjuvant nivolumab in patients with locally advanced clear cell renal cell carcinoma undergoing nephrectomy MI Carlo, K Attalla, Y Mazaheri, S Gupta, O Yildirim, SJ Murray, ... European urology 81 (6), 570-573, 2022 | 50 | 2022 |
| Comprehensive genomic analysis of translocation renal cell carcinoma reveals copy-number variations as drivers of disease progression J Marcon, RG DiNatale, A Sanchez, RR Kotecha, S Gupta, F Kuo, ... Clinical Cancer Research 26 (14), 3629-3640, 2020 | 48 | 2020 |
| DNA damage repair pathway alterations in metastatic clear cell renal cell carcinoma and implications on systemic therapy Y Ged, JL Chaim, RG DiNatale, A Knezevic, RR Kotecha, MI Carlo, ... Journal for immunotherapy of cancer 8 (1), 2020 | 48 | 2020 |
| Multi-institutional competing risks analysis of distant brain failure and salvage patterns after upfront radiosurgery without whole brain radiotherapy for brain metastasis E McTyre, D Ayala-Peacock, J Contessa, C Corso, V Chiang, C Chung, ... Annals of Oncology 29 (2), 497-503, 2018 | 47 | 2018 |
| Nivolumab plus cabozantinib in patients with non-clear cell renal cell carcinoma: results of a phase 2 trial. CH Lee, MH Voss, MI Carlo, YB Chen, E Reznik, A Knezevic, ... Journal of Clinical Oncology 39 (15_suppl), 4509-4509, 2021 | 37 | 2021 |
| Spatiotemporal evolution of the clear cell renal cell carcinoma microenvironment links intra-tumoral heterogeneity to immune escape M Golkaram, F Kuo, S Gupta, MI Carlo, ML Salmans, R Vijayaraghavan, ... Genome Medicine 14 (1), 143, 2022 | 36 | 2022 |
| Trigeminal neuralgia treated with stereotactic radiosurgery: the effect of dose escalation on pain control and treatment outcomes R Kotecha, R Kotecha, S Modugula, ES Murphy, M Jones, R Kotecha, ... International Journal of Radiation Oncology* Biology* Physics 96 (1), 142-148, 2016 | 36 | 2016 |
| Tumor microenvironment dynamics in clear-cell renal cell carcinoma. Cancer Discov. 2019; 9: 1349–1357. doi: 10.1158/2159-8290 L Vuong, RR Kotecha, MH Voss, AA Hakimi CD-19-0499.[Europe PMC free article][Abstract][CrossRef][Academic Search], 0 | 34 | |
| Deciphering radiological stable disease to immune checkpoint inhibitors J Luo, S Wu, H Rizvi, Q Zhang, JV Egger, JC Osorio, AJ Schoenfeld, ... Annals of Oncology 33 (8), 824-835, 2022 | 30 | 2022 |
| Prognosis of incidental brain metastases in patients with advanced renal cell carcinoma RR Kotecha, R Flippot, T Nortman, A Guida, S Patil, B Escudier, ... Journal of the National Comprehensive Cancer Network 19 (4), 432-438, 2021 | 30 | 2021 |
Martin VossAttending Physician, Memorial Sloan Kettering Cancer CenterDirección de correo verificada de mskcc.org
